Christiaan de Jong, MD

Research focus on clinical, pathological, molecular and genomic markers associated with BCG-treatment failure in high-risk non-muscle invasive bladder cancer.

You can read about my project(s) here:

Response to BCG, Digital Pathology, Gene expression profiling